Your browser doesn't support javascript.
loading
Transpyloric feeding is associated with adverse in-hospital outcomes in infants with severe bronchopulmonary dysplasia.
Levin, Jonathan C; Kielt, Matthew J; Hayden, Lystra P; Conroy, Sara; Truog, William E; Guaman, Milenka Cuevas; Abman, Steven H; Nelin, Leif D; Rosen, Rachel L; Leeman, Kristen T.
Afiliação
  • Levin JC; Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. Jonathan.Levin@childrens.harvard.edu.
  • Kielt MJ; Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA.
  • Hayden LP; Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Conroy S; Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA.
  • Truog WE; Children's Mercy Hospital and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
  • Guaman MC; Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
  • Abman SH; Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO, USA.
  • Nelin LD; Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA.
  • Rosen RL; Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Leeman KT; Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
J Perinatol ; 44(2): 307-313, 2024 02.
Article em En | MEDLINE | ID: mdl-38218908
ABSTRACT

OBJECTIVE:

To estimate the association of transpyloric feeding (TPF) with the composite outcome of tracheostomy or death for patients with severe bronchopulmonary dysplasia (sBPD). STUDY

DESIGN:

Retrospective multi-center cohort study of preterm infants <32 weeks with sBPD receiving enteral feedings. We compared infants who received TPF at 36, 44, or 50 weeks post-menstrual age to those who did not receive TPF at any of those timepoints. Odds ratios were adjusted for gestational age, small for gestational age, male sex, and invasive ventilation and FiO2 at 36 weeks.

RESULTS:

Among 1039 patients, 129 (12%) received TPF. TPF was associated with an increased odds of tracheostomy or death (aOR 3.5, 95% CI 2.0-6.1) and prolonged length of stay or death (aOR 3.1, 95% CI 1.9-5.2).

CONCLUSIONS:

Use of TPF in sBPD after 36 weeks was infrequent and associated with worse in-hospital outcomes, even after adjusting for respiratory severity at 36 weeks.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Recém-Nascido Prematuro Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Recém-Nascido Prematuro Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos